Advertisement
Screener

Zoetis Inc. (ZTS) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$79.43(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$79.43High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-06-30ZTS
Zoetis Inc.
Glen SantangeloBarclays$73.25$85.00+16.04%Equal Weight
2025-12-08ZTS
Zoetis Inc.
Glen SantangeloBarclays$120.41$136.00+12.95%Equal Weight
2025-03-25ZTS
Zoetis Inc.
Glen SantangeloBarclays$163.17Overweight
2025-02-13ZTS
Zoetis Inc.
Glen SantangeloBarclays$173.88$244.00+40.33%Overweight
2024-08-06ZTS
Zoetis Inc.
Glen SantangeloBarclays$174.82$242.00+38.43%Overweight
2024-04-23ZTS
Zoetis Inc.
Glen SantangeloBarclays$145.54$230.00+58.03%Overweight
2024-02-14ZTS
Zoetis Inc.
Glen SantangeloBarclays$196.69$260.00+32.19%Overweight
2023-11-03ZTS
Zoetis Inc.
Glen SantangeloBarclays$160.91$255.00+58.47%Overweight

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10